BioCentury | Dec 6, 2010
Company News

London Genetics Ltd., Quintiles sales and marketing update

...assay development services, to biopharmaceutical companies under a non-exclusive alliance. Financial terms were not disclosed. London Genetics Ltd....
BioCentury | Nov 22, 2010
Company News

Astrimmune Ltd., London Genetics Ltd. deal

...Astrimmune's preclinical pancreatic cancer vaccine. Astrimmune said it is providing management and GI expertise, while London Genetics...
...East Midlands Development Agency. Further financial terms were not disclosed. Astrimmune Ltd. , Nottingham, U.K. London Genetics Ltd....
BioCentury | Oct 1, 2010
Politics & Policy

London Genetics' Kleyn joins BIA board

...BioIndustry Association (BIA) appointed Dominique Kleyn as a director. Kleyn is CEO of pharmacogenetics company London Genetics Ltd....
Items per page:
1 - 3 of 3
BioCentury | Dec 6, 2010
Company News

London Genetics Ltd., Quintiles sales and marketing update

...assay development services, to biopharmaceutical companies under a non-exclusive alliance. Financial terms were not disclosed. London Genetics Ltd....
BioCentury | Nov 22, 2010
Company News

Astrimmune Ltd., London Genetics Ltd. deal

...Astrimmune's preclinical pancreatic cancer vaccine. Astrimmune said it is providing management and GI expertise, while London Genetics...
...East Midlands Development Agency. Further financial terms were not disclosed. Astrimmune Ltd. , Nottingham, U.K. London Genetics Ltd....
BioCentury | Oct 1, 2010
Politics & Policy

London Genetics' Kleyn joins BIA board

...BioIndustry Association (BIA) appointed Dominique Kleyn as a director. Kleyn is CEO of pharmacogenetics company London Genetics Ltd....
Items per page:
1 - 3 of 3